TITLE

Metastasis-associated colon cancer-1 is a novel prognostic marker for cervical cancer

AUTHOR(S)
Lan Guo; Wanggui Lu; Xuan Zhang; Dixian Luo; Hongwen Zhang
PUB. DATE
July 2014
SOURCE
International Journal of Clinical & Experimental Pathology;2014, Vol. 7 Issue 7, p4150
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
97436118

 

Related Articles

  • Identification of MACC1 as a novel prognostic marker in hepatocellular carcinoma.  // Journal of Translational Medicine;2011, Vol. 9 Issue 1, p166 

    The article discusses a study which noted the identification of metastasis-associated in colon cancer-1 (MACC1) as a novel prognostic marker in hepatocellular carcinoma (HCC). The study examined MACC1 mRNA expression in 128 HCC tissues by quantitative polymerase chain reaction. The study...

  • MACC1 expression levels as a novel prognostic marker for colorectal cancer. HIROFUMI YAMAMOTO; NORIKATSU MIYOSHI; KOSHI MIMORI; TOSHIKI HITORA; MASAYOSHI TOKUOKA; SHIKI FUJINO; ELLIS, HALEY L.; HIDESHI ISHII; SHINGO NOURA; MASAYUKI OHUE; MASAHIKO YANO; YUICHIRO DOKI; MASAKI MORI // Oncology Letters;2014, Vol. 8 Issue 5, p2305 

    Metastasis-associated in colon cancer-1 (MACC1) is key in promoting tumor proliferation and invasion, and is mediated by the hepatocyte growth factor (HGF) and mesenchymal- epithelial transition factor. Previous reports have revealed that MACC1 is a novel oncogene that is expressed in various...

  • DIY HEALTH TEST. LOUISE ATKINSON // Daily Mail;5/ 7/2013, p46 

    CERVICAL CANCER

  • Young age as a prognostic factor in cervical cancer: analysis of population based data from 10 022 cases. Meanwell, Clive A.; Kelly, Krystyna A.; Wilson, Susan; Roginski, Claudia; Woodman, Ciaran; Griffiths, Rod; Blackledge, George // British Medical Journal (Clinical Research Edition);2/6/1988, Vol. 296 Issue 6619, p386 

    Analyzes the population based data of cervical cancer in young age in Great Britain. Suggestion of young age as a poor prognostic factor for cervical cancer; Determination of the prognostic effect of age; Estimation of survival distributions of cervical cancer.

  • Ubiquitin-specific protease 22: a novel molecular biomarker in cervical cancer prognosis and therapeutics. Yang, Meng; Liu, Yun-Duo; Wang, Yan-Ying; Liu, Tian-Bo; Ge, Ting-Ting; Lou, Ge // Tumor Biology;Feb2014, Vol. 35 Issue 2, p929 

    Ubiquitin-specific protease 22 (USP22) exhibits an important function in tumor progression and oncogenesis. The aim of this study was to investigate the role of USP22 and the association with its potential targets in patients with cervical cancer. To our knowledge, this is the first study that...

  • URG4 overexpression is correlated with cervical cancer progression and poor prognosis in patients with early-stage cervical cancer. Lan Zhang; He Huang; Longjuan Zhang; Teng Hou; Shu Wu; Qidan Huang; Libing Song; Jihong Liu // BMC Cancer;2014, Vol. 14 Issue 1, p1 

    Background Upregulator of cell proliferation 4 (URG4) has been implicated in the oncogenesis of certain cancers. However, the correlation between URG4 expression and clinicopathological significance in human cancer remains unclear. Therefore, this study investigated its expression and...

  • Serum microRNA-205 as a novel biomarker for cervical cancer patients. Quanhui Ma; Guiping Wan; Shuxia Wang; Wanwei Yang; Jiaming Zhang; Xiaoming Yao // Cancer Cell International;2014, Vol. 14 Issue 1, p1 

    Objective Serum microRNAs (miRNAs) are a novel class of diagnostic and prognostic biomarkers for numerous cancers. However, the level and clinical relevance of circulating miR-205 transcripts in human serum of cervical cancer patients are unclear. The purpose of this study was to determine serum...

  • NR2F6 Expression Correlates with Pelvic Lymph Node Metastasis and Poor Prognosis in Early-Stage Cervical Cancer. Chunhao Niu; Xiaoying Sun; Weijing Zhang; Han Li; Liqun Xu; Jun Li; Benke Xu; Yanna Zhang // International Journal of Molecular Sciences;Oct2016, Vol. 17 Issue 10, p1694 

    Background: There is an abnormal expression of nuclear receptor subfamily 2 group F member 6 (NR2F6) in human cancers such as breast cancer, colon cancer, and acute myelogenous leukemia. However, its clinical significance in cervical cancer has not been established. We explored NR2F6 expression...

  • MACC1, a newly identified key regulator of HGF-MET signaling, predicts colon cancer metastasis. Stein, Ulrike; Walther, Wolfgang; Arlt, Franziska; Schwabe, Holger; Smith, Janice; Fichtner, Iduna; Birchmeier, Walter; Schlag, Peter M // Nature Medicine;Jan2009, Vol. 15 Issue 1, p59 

    We identified a previously undescribed gene associated with colon cancer by genome-wide expression analysis in primary and metastatic carcinomas: metastasis-associated in colon cancer-1, MACC1. MACC1 expression in tumor specimens is an independent prognostic indicator of metastasis formation and...

  • Correlation of NGX6 expression with clinicopathologic features and prognosis in colon cancer. Jidong Xiao; Yuanquan Zhou; Bo Liu // International Journal of Clinical & Experimental Medicine;2015, Vol. 8 Issue 8, p13644 

    Objective: The aim was to explore the correlation of NGX6 expression with clinicopathological features and prognosis in colon cancer. Methods: Clinicopathological feature of 145 patients with colon cancer were analyzed. NGX6 expression was measured using immunohistochemistry methods. The...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics